Evolent Historical Financial Ratios
| EVH Stock | USD 12.21 0.96 8.53% |
Evolent Health is recently reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 3.61 or Days Sales Outstanding of 76.62 will help investors to properly organize and evaluate Evolent Health financial condition quickly.
Evolent |
About Evolent Financial Ratios Analysis
Evolent HealthFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Evolent Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Evolent financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Evolent Health history.
Evolent Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Evolent Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Evolent Health sales, a figure that is much harder to manipulate than other Evolent Health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Evolent Health dividend as a percentage of Evolent Health stock price. Evolent Health dividend yield is a measure of Evolent Health stock productivity, which can be interpreted as interest rate earned on an Evolent Health investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Evolent Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Evolent Health current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.As of now, Evolent Health's Operating Cash Flow Per Share is increasing as compared to previous years. The Evolent Health's current PB Ratio is estimated to increase to 3.61, while Price To Sales Ratio is projected to decrease to 1.78.
| 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.005657 | 0.005114 | 0.007152 | Price To Sales Ratio | 1.95 | 1.87 | 1.78 |
Evolent Health fundamentals Correlations
Click cells to compare fundamentals
Evolent Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evolent Health fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 2.46 | 0.88 | 1.33 | 1.95 | 1.87 | 1.78 | |
| Ptb Ratio | 0.81 | 2.2 | 3.43 | 3.06 | 3.44 | 3.61 | |
| Days Sales Outstanding | 33.39 | 44.41 | 52.5 | 68.76 | 83.03 | 76.62 | |
| Book Value Per Share | 11.28 | 7.3 | 8.06 | 9.17 | 9.6 | 9.12 | |
| Free Cash Flow Yield | (0.1) | (0.0336) | 0.00578 | (0.019) | 0.031 | 0.0325 | |
| Operating Cash Flow Per Share | (0.52) | (0.19) | 0.45 | (0.12) | 1.28 | 1.35 | |
| Stock Based Compensation To Revenue | 0.0185 | 0.0143 | 0.0184 | 0.0251 | 0.0206 | 0.0196 | |
| Capex To Depreciation | 0.58 | 0.48 | 0.42 | 0.57 | 0.23 | 0.22 | |
| Pb Ratio | 0.81 | 2.2 | 3.43 | 3.06 | 3.44 | 3.61 | |
| Ev To Sales | 1.2 | 1.35 | 2.64 | 2.16 | 2.1 | 2.0 | |
| Free Cash Flow Per Share | (0.95) | (0.54) | 0.16 | (0.53) | 1.02 | 1.07 | |
| Roic | (0.092) | (0.0409) | 0.0335 | (0.0141) | (0.0238) | (0.0226) | |
| Inventory Turnover | (3.42) | (1.58) | (2.13) | (2.49) | (2.24) | (2.35) | |
| Net Income Per Share | (3.71) | (3.94) | (0.35) | (0.2) | (1.02) | (1.07) | |
| Days Of Inventory On Hand | (106.77) | (231.63) | (171.09) | (146.62) | (168.61) | (177.04) | |
| Payables Turnover | 13.69 | 21.94 | 6.84 | 18.11 | 31.16 | 32.72 | |
| Sales General And Administrative To Revenue | 0.49 | 0.46 | 0.3 | 0.24 | 0.28 | 0.55 | |
| Research And Ddevelopement To Revenue | 0.0234 | 0.0148 | 0.0171 | 0.02 | 0.023 | 0.0397 | |
| Capex To Revenue | 0.042 | 0.0288 | 0.0275 | 0.0284 | 0.0146 | 0.0139 | |
| Cash Per Share | 1.25 | 4.05 | 3.97 | 2.16 | 1.73 | 1.65 | |
| Pocfratio | (17.48) | (83.91) | 61.46 | (227.74) | 25.77 | 27.06 | |
| Interest Coverage | (8.28) | (1.34) | 1.19 | (3.84) | (1.31) | (1.38) | |
| Capex To Operating Cash Flow | (0.83) | (1.82) | 0.64 | (3.32) | 0.2 | 0.21 | |
| Pfcf Ratio | (9.53) | (29.79) | 173.02 | (52.71) | 32.28 | 33.89 | |
| Days Payables Outstanding | 26.67 | 16.64 | 53.34 | 20.15 | 11.71 | 11.13 | |
| Income Quality | 0.14 | 0.0485 | (1.03) | 0.6 | (1.26) | (1.2) | |
| Roe | (0.33) | (0.54) | (0.0437) | (0.0218) | (0.11) | (0.1) | |
| Ev To Operating Cash Flow | (23.76) | (85.1) | 61.83 | (252.66) | 28.94 | 30.39 | |
| Pe Ratio | (2.44) | (4.07) | (78.64) | (140.69) | (32.51) | (34.13) | |
| Return On Tangible Assets | (0.0851) | (0.49) | (0.45) | (0.0425) | (0.0287) | (0.15) | |
| Ev To Free Cash Flow | (12.96) | (30.21) | 174.05 | (58.48) | 36.25 | 38.06 | |
| Earnings Yield | (0.41) | (0.25) | (0.0127) | (0.007108) | (0.0308) | (0.0323) | |
| Intangibles To Total Assets | 0.64 | 0.59 | 0.45 | 0.5 | 0.7 | 0.39 | |
| Net Debt To E B I T D A | (1.09) | (0.0799) | 0.25 | 6.58 | (18.24) | (17.32) | |
| Receivables Turnover | 10.93 | 8.22 | 6.95 | 5.31 | 4.4 | 4.88 | |
| Graham Number | 30.57 | 25.42 | 7.99 | 6.42 | 14.81 | 14.07 | |
| Shareholders Equity Per Share | 11.2 | 7.3 | 8.06 | 9.17 | 9.6 | 9.12 |
Currently Active Assets on Macroaxis
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 21.554 | Quarterly Revenue Growth 0.216 | Return On Assets 0.0073 | Return On Equity (0.06) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.